Creating a daily measure of depression for people with aphasia
Developing a daily life measure of depression for persons with aphasia and examining its relation with communicative confidence
['FUNDING_OTHER'] · REHABILITATION INSTITUTE OF CHICAGO D/B/A SHIRLEY RYAN ABILITYLAB · NIH-10984447
This study is creating an easy-to-use mobile tool for people with aphasia to share how they're feeling every day, helping to better understand their mood changes and support their mental health after a stroke.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | REHABILITATION INSTITUTE OF CHICAGO D/B/A SHIRLEY RYAN ABILITYLAB (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10984447 on ClinicalTrials.gov |
What this research studies
This research focuses on individuals with aphasia, a language disorder often resulting from a stroke, who experience higher rates of depression. The study aims to develop a user-friendly tool that allows these individuals to report their mood in real-time using mobile technology. By employing ecological momentary assessment (EMA), the research will capture daily fluctuations in mood, providing a more accurate picture of depression in this population. The tool will be designed with input from patients, caregivers, and speech-language pathologists to ensure it meets the needs of those affected.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with aphasia following a stroke who may also be experiencing symptoms of depression.
Not a fit: Patients who do not have aphasia or those who are not experiencing depression may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better assessment and management of depression in individuals with aphasia, ultimately improving their quality of life.
How similar studies have performed: While the use of ecological momentary assessment has been successful in other populations, its application in individuals with aphasia is relatively novel and untested.
Where this research is happening
CHICAGO, UNITED STATES
- REHABILITATION INSTITUTE OF CHICAGO D/B/A SHIRLEY RYAN ABILITYLAB — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ASHAIE, SAMEER AFZAL — REHABILITATION INSTITUTE OF CHICAGO D/B/A SHIRLEY RYAN ABILITYLAB
- Study coordinator: ASHAIE, SAMEER AFZAL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease